First Time Loading...

Cardiff Oncology Inc
NASDAQ:CRDF

Watchlist Manager
Cardiff Oncology Inc Logo
Cardiff Oncology Inc
NASDAQ:CRDF
Watchlist
Price: 3.46 USD -1.7% Market Closed
Updated: May 7, 2024

Cardiff Oncology Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cardiff Oncology Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Cardiff Oncology Inc
NASDAQ:CRDF
Cash from Investing Activities
$36.2m
CAGR 3-Years
N/A
CAGR 5-Years
348%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
-76%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$27.8B
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$4.6B
CAGR 3-Years
-89%
CAGR 5-Years
-21%
CAGR 10-Years
-26%

See Also

What is Cardiff Oncology Inc's Cash from Investing Activities?
Cash from Investing Activities
36.2m USD

Based on the financial report for Dec 31, 2023, Cardiff Oncology Inc's Cash from Investing Activities amounts to 36.2m USD.

What is Cardiff Oncology Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
348%

Over the last year, the Cash from Investing Activities growth was -5%.